These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16226518

  • 21. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M, Liu Q, Min H, Du H, Hu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [Abstract] [Full Text] [Related]

  • 22. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M, Ganesh SK, Biswas J.
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [Abstract] [Full Text] [Related]

  • 23. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
    Jap A, Luu CD, Yeo I, Chee SP.
    Eye (Lond); 2008 Feb; 22(2):240-5. PubMed ID: 16980924
    [Abstract] [Full Text] [Related]

  • 24. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P, Wang H, Zhou H, Zhong H, Li F, Huang X, Zhong H, Fu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [Abstract] [Full Text] [Related]

  • 25. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W, Zhou H, Yang P, Huang X, Wang L, Kijlstra A.
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [Abstract] [Full Text] [Related]

  • 26. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS.
    Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2007 Mar; 114(3):591-8. PubMed ID: 17123624
    [Abstract] [Full Text] [Related]

  • 27. Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye.
    Galor A, Davis JL, Flynn HW, Feuer WJ, Dubovy SR, Setlur V, Kesen MR, Goldstein DA, Tessler HH, Ganelis IB, Jabs DA, Thorne JE.
    Am J Ophthalmol; 2009 Nov; 148(5):704-710.e2. PubMed ID: 19665105
    [Abstract] [Full Text] [Related]

  • 28. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
    Urzua CA, Velasquez V, Sabat P, Berger O, Ramirez S, Goecke A, Vásquez DH, Gatica H, Guerrero J.
    Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265
    [Abstract] [Full Text] [Related]

  • 29. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC, Kempen JH, Dunn JP, Vogelsang G, Jabs DA.
    Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
    [Abstract] [Full Text] [Related]

  • 30. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
    Bacsal K, Wen DS, Chee SP.
    Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
    [Abstract] [Full Text] [Related]

  • 31. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A, Yamashiro K, Yamamoto K, Nonaka A, Fujihara M, Kurimoto Y.
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [Abstract] [Full Text] [Related]

  • 32. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
    Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D.
    Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
    [Abstract] [Full Text] [Related]

  • 34. Vogt-Koyanagi-Harada disease.
    Damico FM, Kiss S, Young LH.
    Semin Ophthalmol; 2005 Sep; 20(3):183-90. PubMed ID: 16282153
    [Abstract] [Full Text] [Related]

  • 35. Revised diagnostic criteria for vogt-koyanagi-harada disease: considerations on the different disease categories.
    da Silva FT, Damico FM, Marin ML, Goldberg AC, Hirata CE, Takiuti PH, Olivalves E, Yamamoto JH.
    Am J Ophthalmol; 2009 Feb; 147(2):339-345.e5. PubMed ID: 18992868
    [Abstract] [Full Text] [Related]

  • 36. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [Abstract] [Full Text] [Related]

  • 37. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y, Gaudio PA.
    Ocul Immunol Inflamm; 2008 Aug; 16(4):167-71. PubMed ID: 18716952
    [Abstract] [Full Text] [Related]

  • 38. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M.
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [Abstract] [Full Text] [Related]

  • 39. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
    Veerappan M, Fleischman D, Ulrich JN, Stinnett SS, Jaffe GJ, Allingham RR.
    Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
    [Abstract] [Full Text] [Related]

  • 40. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, Satoh H, Ohno S.
    Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.